- Home
- FGEN vs CLPS Comparison
FGEN vs CLPS Comparison
Compare FGEN & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- CLPS
- Stock Information
- Founded
- FGEN 1993
- CLPS 2005
- Country
- FGEN United States
- CLPS Hong Kong
- Employees
- FGEN N/A
- CLPS N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- FGEN Health Care
- CLPS Technology
- Exchange
- FGEN Nasdaq
- CLPS Nasdaq
- Market Cap
- FGEN 45.1M
- CLPS 26.8M
- IPO Year
- FGEN 2014
- CLPS 2018
- Fundamental
- Price
- FGEN $8.52
- CLPS $0.95
- Analyst Decision
- FGEN Strong Buy
- CLPS
- Analyst Count
- FGEN 2
- CLPS 0
- Target Price
- FGEN $146.50
- CLPS N/A
- AVG Volume (30 Days)
- FGEN 36.6K
- CLPS 50.8K
- Earning Date
- FGEN 11-10-2025
- CLPS 10-17-2025
- Dividend Yield
- FGEN N/A
- CLPS 12.87%
- EPS Growth
- FGEN N/A
- CLPS N/A
- EPS
- FGEN 53.38
- CLPS N/A
- Revenue
- FGEN $8,298,000.00
- CLPS $164,481,414.00
- Revenue This Year
- FGEN N/A
- CLPS N/A
- Revenue Next Year
- FGEN N/A
- CLPS N/A
- P/E Ratio
- FGEN $0.16
- CLPS N/A
- Revenue Growth
- FGEN N/A
- CLPS 15.17
- 52 Week Low
- FGEN $4.85
- CLPS $0.82
- 52 Week High
- FGEN $21.94
- CLPS $1.88
- Technical
- Relative Strength Index (RSI)
- FGEN 26.03
- CLPS 57.77
- Support Level
- FGEN $8.50
- CLPS $0.84
- Resistance Level
- FGEN $11.39
- CLPS $0.93
- Average True Range (ATR)
- FGEN 0.52
- CLPS 0.06
- MACD
- FGEN -0.20
- CLPS 0.01
- Stochastic Oscillator
- FGEN 5.21
- CLPS 100.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About CLPS CLPS Incorporation
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.